16
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and safety of single-dose mizoribine for patients with rheumatoid arthritis: results at 6 months after switching from a multiple-dose regimen without a change in total daily dose

, , , , , , & show all
Pages 158-163 | Received 21 Jul 2010, Accepted 14 Oct 2010, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Chihiro Terai, Tomomi Tsutsumi, Tadashi Sakurai, Masato Moriguchi, Takanori Azuma, Motohide Kaneko, Mitsuhiro Kawagoe, Kenta Hoshi, Hide Yoshida, Toshimichi Matsui, Kyoichi Nakajima, Ayumi Okuyama, Eiko Nishi, Koichi Amano, Muneo Ota, Toshihide Mimura, Kentaro Chino, Kazutoshi Aoki, Yuichi Handa, Tatsuo Hirose, Issei Kida, Shigeto Kobayashi, Kimihiro Suzuki, Tsuyoshi Matsuzaki & Yoshiaki Kuga. (2014) The efficacy of mizoribine for the treatment of rheumatoid arthritis and its correlation with renal function. Modern Rheumatology 24:6, pages 892-896.
Read now
Hideo Ohtsubo, Sanae Ohkura, Masaki Akimoto, Yoshiya Arishima, Nobuhiko Sunahara, Tomomaro Izumihara, Nobutaka Eiraku, Tamami Yoshitama & Takemasa Matsuda. (2012) An investigation of the correlation between blood concentration of mizoribine and its efficacy in treatment of rheumatoid arthritis based on indices of drug survival and improvement in DAS28-CRP. Modern Rheumatology 22:6, pages 837-843.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.